Inactive Instrument

Press Releases Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Galapagos : Galapagos reports first quarter 2024 financial results	03/05	PU
Galapagos reports first quarter 2024 financial results	03/05	GL
Galapagos : Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	01/05	PU
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	01/05	GL
Galapagos : Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	05/04	PU
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	05/04	GL
Galapagos : Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	29/03	PU
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	29/03	GL
Galapagos : Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur	27/03	PU
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board	27/03	GL
Galapagos announces full year 2023 results and outlook for 2024	23/02	GL
Galapagos presents at EBMT-EHA annual meeting 2024	16/02	GL
Galapagos presents at EBMT-EHA annual meeting 2024	16/02	AQ
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	01/02	GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	05/01	GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	05/01	AQ
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology	04/01	GL
Galapagos signs agreement to transfer Jyseleca business to Alfasigma	03/01	AQ
Galapagos : Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	02/01	PU
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	02/01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

Press Releases

Filters